Top 40 Medical Angel Investors in France (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bernard Majoie
Angel
|
3 | France, Belgium | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Care | $1.3M–$2.7M |
|
Bertrand Jelensperger
Angel
|
2 | France, Spain, Belgium | Seed, Series A, Angel | Apps, Software, E-Commerce | $1M–$11M |
|
Nicolas Dessaigne
Angel
|
2 | United States, France, Germany | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, SaaS | $500k–$25M |
|
André-Jacques Auberton-Hervé
Angel
|
2 | France | Seed, Series A | Medical, Biotechnology | |
|
Pierre Kosciusko-Morizet
Angel
|
2 | France, Israel, United States | Seed, Series A, Angel | Retail, Internet, E-Commerce | $511k–$57M |
|
Guillaume Richard
Angel
|
2 | France | Pre-Seed, Series A | Medical, Software, Health Care | |
|
Nicolas Douay
Angel
|
2 | France, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $500k–$14M |
|
Daniel Caille
Angel
|
2 | France | Series A, Pre-Seed | Health Care, Elderly, Medical | $4.4M–$5.1M |
|
Flavien Kulawik
Angel
|
1 | France, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Health Care | $1.3M–$7M |
|
Alain Tingaud
Angel
|
1 | France, Luxembourg, United States | Pre-Seed, Seed | Software, E-Commerce, Cryptocurrency | $1.1M–$5M |
|
Bernard Chauvin
Angel
|
1 | France | Series A, Series C | Medical, Health Care, Medical Device | |
|
John Gridley
Angel
|
1 | France | Pre-Seed, Series A | Medical, Health Care, Medical Device | |
|
Charles-Edouard Bouee
Angel
|
1 | United States, France, Vietnam | Pre-Seed, Seed, Angel | Biotechnology, Natural Resources, AgTech | $348k–$1M |
|
Pierre Krings
Angel
|
1 | France | Seed, Series A | Construction, Rental, Retail | |
|
Marie Outtier
Angel
|
1 | France, United States, The Netherlands | Seed, Pre-Seed | Software, Health Care, Information Technology | $876k–$4.9M |
|
Victor Douce
Angel
|
1 | United States, France, Germany | Series C, Pre-Seed, Series A | Health Care, FinTech, Medical | $175M–$650M |
|
Tony Jamous
Angel
|
1 | United States, United Kingdom, France | Seed, Series A, Pre-Seed | Software, SaaS, Developer APIs | $125k–$12M |
|
Philippe ODDO
Angel
|
1 | France, United States | Seed, Series B, Series C | Apps, Web3, Banking | $1.3M–$2.5M |
|
Christophe Cervasel
Angel
|
1 | France | Seed | Wellness, Agriculture, Animal Feed | $1.3M–$1.4M |
|
Armand Bensussan
Angel
|
1 | France | Seed | Medical, Biotechnology, Consumer Research | |
|
Sebastien Gallice
Angel
|
1 | France | Seed | Medical, 3D Printing, Pharmaceutical | |
|
Gilles Alberici
Angel
|
1 | France | Seed | Medical, Biotechnology, Consumer Research | |
|
Philippe du Mesnil
Angel
|
1 | France | Medical, Manufacturing, Medical Device | ||
|
David Amsellem
Angel
|
1 | France | Seed, Angel | Financial Services, Banking, FinTech | $1.2M–$3.2M |
|
Laurent SALOMON
Angel
|
1 | France | Series A | Medical, Health Care, Medical Device | |
|
Geoffrey Duyk
Angel
|
1 | United States, Japan, France | Series A, Series B, Series C | Biotechnology, Medical, Chemical | $10M–$100M |
|
Giorgio Anania
Angel
|
1 | France | Seed | Medical, Biotechnology | |
|
Félix Blossier
Angel
|
1 | France, Italy, United States | Series A, Seed | SMS, SaaS, FinTech | $13M–$33M |
|
Sacha Loiseau
Angel
|
1 | France | Series A, Pre-Seed, Series B | Health Care, Medical Device, Medical | $8.2M–$31M |
|
Jean-Paul Kress
Angel
|
1 | France | Seed | Medical, Biotechnology | |
|
Olivier Occelli
Angel
|
1 | France | Seed | Medical, Hospital, Health Care | |
|
Rémi Gaston- Dreyfus
Angel
|
1 | France | Seed | Medical, Biotechnology | |
|
Jeanne Kehren
Angel
|
1 | France | Seed | Medical, Health Care, Neuroscience | |
|
Yann Fleureau
Angel
|
1 | France | Series A, Seed, Pre-Seed | Health Care, Medical Device, Gaming | $11M–$31M |
|
Arthur Mensch
Angel
|
1 | United States, Spain, France | Series A, Seed, Pre-Seed | Artificial Intelligence, Medical, Software | $10M–$52M |
|
Pierre Olivier Goineau
Angel
|
1 | France | Medical, Biopharma, Health Care | ||
|
Dominique Vidal
Angel
|
1 | France, United States, United Kingdom | Series A, Seed, Series B | Software, Internet, E-Commerce | $1M–$69M |
|
Antoine Freysz
Angel
|
1 | France | Seed, Series A, Pre-Seed | SaaS, Internet, Software | $329k–$11M |
|
Quentin de Metz
Angel
|
1 | France, United States | Seed, Series A | FinTech, Medical, Hospital | $9M–$33M |
|
Guillaume Amblard
Angel
|
1 | France, United Kingdom, Tunisia | Seed, Series A, Venture - Series Unknown | Software, FinTech, Analytics | $630k–$9.5M |
| Access all 50 angel investors in France Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bernard Majoie - President @ Fournier-Majoie
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: France, Belgium
Investor stats
- Total investments: 6
- Round size: Seed $1.3M–$2.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Bertrand Jelensperger is the Co-Founder and Advisory Board at TheFork.
Show more...Investment focus
- Industry: Apps, Software, E-Commerce
- Stage:Seed, Series A, Angel
- Geography: France, Spain, Belgium
Investor stats
- Total investments: 15
- Round size: Seed $1.1M–$7.1M; Angel $1M–$2.8M; Series A $4.4M–$11M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Malou — Malou offers food marketing and digital marketing solutions for restaurants. The company also offers content management, restaurant marketing, reputation management, presence management, and SEO solutions.
- Kiliba — 100% automated emailing platform: design of html templates in your colours, sending of personalised emails, marketing automation workflows, enriched CRM
- Neptune Elements — Neptune Elements produces edible seaweed intended to democratize algae in food and develop the entire sector. They offer seaweed made up of algae that contains a variety of nutrients, vitamins, proteins, and minerals, enabling consumers to eat healthy food and boost their immunity and health.
Nicolas is a firm believer of “culture-first” companies and am focused on building just that at Algolia where team empowerment is how they accomplish their goals. Prior to co-founding Algolia with Julien, he spent over 12 years working on information retrieval at Exalead and Thales.At Algolia they believe every website and app deserves greatsearch! they offer a hosted Search API that helps developers deliver an instant and relevant search experience. We’ve seen that search is a great touch point to optimize – they regularly see double digit increases in engagement on sites when they improve their search UX.When they founded Algolia in 2012 it was originally going to be a local SDK for mobile app search. They changed direction and realized that they needed to offer search as a hosted SaaS service, but it was those early mobile optimizations that gave us their unique advantage. They are one of the few search solutions that has been developed from scratch, and they never would have gone that direction if they hadn’t originally been focused on mobile search.His focus has been first and foremost on making Algolia a great place to work. They have a unique culture here that values ownership as its pillar. They want to create a company where every team member takes initiative, gets out of their comfort zone, is empowered to make decisions; in short: be free to be their best.He is recently spoken at SaaStock on the challenges of running a company based in both Paris and San Francisco. His priority lately has been on scaling their growth and ramping up their team size.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, France, Germany
Investor stats
- Total investments: 239
- Round size: Seed $1.6M–$10M; Pre-Seed $500k–$550k; Series A $8M–$25M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- Decima2 — Stop wasting money on Google Ads that don't convert. Decima2 finds what actually works, tests new approaches, and scales your winners.
- Vybe — AI coworkers and custom apps that runs your operations.
- Upstream — The first inbox designed for humans and agents.
Dr. André-Jacques Auberton-Hervé co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-Hervé is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-Hervé managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 µm and 0.8 µm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-Hervé was elected to serve as the European representative to SEMI’s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-Hervé is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cut™ technology and his overall contributions to the semiconductor industry as a whole. Auberton-Hervé is a member of the Electrochemical Society and the IEEE.
Show more...Investment focus
- Industry: Medical, Biotechnology
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Pierre Kosciusko-Morizet is an Internet entrepreneur, founder and former CEO of French e-commerce pioneer PriceMinister. After he sold Priceminister to Japanese internet giant Rakuten in 2010 for $350m, he became Rakuten Europe COO. He left Rakuten in 2014 so as to concentrate on his investments and new project.Pierre Kosciusko-Morizet is agraduate of the famous HEC Paris business school, where he studied entrepreneurship. He launched his first company, Visualis SA (a consultancy for the distribution sector), while still studying at HEC, with a €10,000 student loan. After graduating from HEC, Kosciusko-Morizet moved to the United States and became a manager in the marketing department of Finance Capital One, an internet-based credit card company. There he managed a team of 60 analysts, and specialised in the online credit and banking market.It was there that Kosciusko-Morizet saw a gap in the market. While websites existed in the United States linking buyers and sellers online, there was no equivalent site in France. He resigned from Finance Capital One and returned to France two weeks later to work on what would become PriceMinister with Pierre Krings, Olivier Mathiot, Nathalie Maurin and Justin Ziegler. In 2001 Priceminister launched and has grown into one of the largest and most successful e-commerce companies in France, currently employing around 200 passionate and dedicated staff.Pierre Kosciusko-Morizet is a former President of the ACSEL (Association of the Digital Economy) and of the ASIC (Association of Internet Community Services), and Chairman and main investor of the Strategic Committee of ISAI, the “French internet entrepreneurs fund”, that raised over $100m. In 2010 Kosciusko-Morizet published an autobiographical book which details the story of PriceMinister.
Show more...Investment focus
- Industry: Retail, Internet, E-Commerce
- Stage:Seed, Series A, Angel
- Geography: France, Israel, United States
Investor stats
- Total investments: 39
- Round size: Seed $511k–$5M; Angel $1.1M–$15M; Series A $3.3M–$57M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- youzd — youzd is an e-commerce platform for second-hand furniture, electronics, and decoration products.
- Wecasa — Wecasa is a data-driven marketplace that revolutionizes care services by focusing on user experience for customers and professionalsWecasa's mission is to make care services simple and accessible for a better quality of life. Through its app, users can book in seconds a reliable Professional for care services at home: wellness (haircut,beauty, massage), cleaning, and childcare. Available in Paris, top cities in France, London, and more European cities to come. Wecasa is proud to help 100.000+ customers and increase the business of 3000 independent professionals.
- Tracktor — Tracktor is an platform that enables construction companies to rent and purchase construction equipment efficiently.
Guillaume Richard is the Founder, Chairman & CEO at Oui Care.He attended EDHEC Business School.
Show more...Investment focus
- Industry: Medical, Software, Health Care
- Stage:Pre-Seed, Series A
- Geography: France
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
Previously cofounder @ Keldoc - currently early stage investor @ Better Angle
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 59
- Round size: Seed $768k–$5.3M; Pre-Seed $500k–$8.6M; Series A $6.4M–$14M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Samp — Whatever the scale, age, or number of facilities, Shared Reality helps industrial operators accelerate their digital twin programs in an affordable and accessible way.
- Djamo — Djamo is a Provider of financial applications to allow customers to use their cards with zero fees in a wide range of services.
- underdog — underdog is a simplified & refurbished household appliances.
Daniel Caille
Show more...Investment focus
- Industry: Health Care, Elderly, Medical
- Stage:Series A, Pre-Seed
- Geography: France
Investor stats
- Total investments: 4
- Round size: Series A $4.4M–$5.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
- Medylink — Medylink has designs and develops a digital platform that allows general practitioners to coordinate their actions with specialists.
- CetteFamille — CetteFamille is an economical alternative to retirement homes in France. It is a French network of professional and accredited families to welcome the elderly.CetteFamille is a warm, economical and tailor-made alternative to the retirement home. CetteFamille is a site of connection and a company of services to the person allowing seniors to finda trained and selected family close to home. CetteFamille offers seniors and their families an offer of contact and a follow-up service to carry out all the administrative procedures.On www.cettefamille.com, caregivers of seniors can register to meet a family available nearby. The teams at CetteFamille are responsible for contacting them to study the request and ensure a meeting with the family most appropriate to meet his needs.
Flavien Kulawik
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: France, United Kingdom
Investor stats
- Total investments: 14
- Round size: Seed $1.3M–$7M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Claimy — Integrate Claimy to unlock the full potential of your catalogue, recover missing royalties, and gain real-time insights into your performances.
- HrFlow.ai — Meet the first AI agents and Foundation models trained on billions of interview outcomes. The Hiring SuperIntelligence predicts your next hires and who's worth meeting, saving managers thousands of hours wasted on false positives.
- Piston — Piston is the first Agentic ERP that thinks, advises, and executes tasks autonomously, so revenue grows while your team stays lean.
Alain Tingaud is a Founder & CEO at Alain Tingaud Innovations.
Show more...Investment focus
- Industry: Software, E-Commerce, Cryptocurrency
- Stage:Pre-Seed, Seed
- Geography: France, Luxembourg, United States
Investor stats
- Total investments: 5
- Round size: Seed $1.4M–$5M; Pre-Seed $1.1M–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Gonuggets — We help digitally native brands to grow their e-commerce revenue on marketplaces such as Amazon and D2C across EMEA.
- MarketLeap — Breaking E-commerce Barriers with Software. MarketLeap is managing all the complexities of selling and growing on marketplaces worldwide.
- Trendex — Trendex is a YC-backed, fast-growing tech startup working with the world's most famous and most promising athletes to build new revenue streams and engagement opportunities for talents and fans around the world...
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Bernard Chauvin, a renowned authority in the field of ophthalmology, sits on the company's Board of Directors.March 12, 2013 – EyeTechCare SA, has secured a third round of funding amounting to EUR 10 million. Bernard Chauvin, a private investor, has taken an equity stake in the company alongside two of the existing investors which alsocontributed to this round of funding: the capital investment company Omnes Capital (formerly Crédit Agricole Private Equity) and the Lyon-based insurer SHAM. Bernard Chauvin is a physician specializing in ophthalmology. He headed the Laboratoires Chauvin for 27 years (until its acquisition by Bausch & Lomb), prior to joining Neurotech, a French biotechnology company where he served as Chief Executive Officer until 2004. Since then, he has taken an active role as a director in the development of a number of pharmaceutical and biotechnology companies.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A, Series C
- Geography: France
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- EyeTechCare — EyeTechCare has developed a new medical device called EyeOP1. This leading edge technology device is the result of several years of joint research with INSERM which has led to the development of a treatment method using High Intensity Focused Ultrasound (HIFU).EyeOP1 is an ultrasound device which offers a non-invasive treatment for refractoryglaucoma. This new method is extremely accurate, simple and only takes one minute.
- Ciliatech — Ciliatech is a medtech company specialized in ophthalmology, develops a new class of implant to address the increasing need to treat glaucoma durably and with very minimal adverse effects.
John Gridley is the Advisor & Partner at Independent.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Pre-Seed, Series A
- Geography: France
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- HyprView — HyprView builds the world's first clinical-grade, label-free imaging platform with photonics and AI for precision oncology diagnostics.
- BrightHeart — BrightHeart develops an AI-based platform for fetal ultrasound analysis to improve detection of congenital heart defects.
Charles-Edouard Bouée is the CEO of Roland Berger. He is a seasoned expert in reorganization, post-merger projects and integration programs, as well as performance improvement, and specializes in disruptive innovation, new technologies and digital transformation.Charles-Edouard Bouée joined Roland Berger in 2001 as Senior Partner in the Parisoffice, where he headed the Financial Services and Energy & Utility Competence Centers. He became the Managing Partner of Roland Berger’s China office in 2006 and Head of the Asia Leadership Team in 2009.He then assumed responsibility for France, Belgium, Italy, Spain and Morocco. He has since fulfilled consulting mandates for leading international companies and organizations based in Europe, Asia and elsewhere. Charles-Edouard Bouée was appointed COO in July 2013 and elected CEO of Roland Berger in June 2014.Charles-Edouard Bouée has authored various books on modern management and China, as well as Artificial Intelligence.
Show more...Investment focus
- Industry: Biotechnology, Natural Resources, AgTech
- Stage:Pre-Seed, Seed, Angel
- Geography: United States, France, Vietnam
Investor stats
- Total investments: 5
- Round size: Pre-Seed $348k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- xRapid — xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence. xRapid is a Biotech startup based in Aix en Provence (France), London (Uk), and Las Vegas. xRapid saw its beginnings in a laboratory in Jakarta. Their CTO, Professor David Mendels, recognized that he was able to develop a mobilesolution for malaria diagnosis after attending a conference. Since then he has created xRapid, a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhea.
- PaySika — Un compte, une carte bancaire gratuite
- INTERSTELLAR LAB — Interstellar Lab is a biotech company founded in 2018 that develops, manufactures and operates advanced bio-farming platforms to help its customer produce the cleanest plant-based ingredients. Its bio-farming technology combines automated farms (Biopods), AI and bioscience with a unique data-driven approach. Its considerably accelerates plantgrowth while optimizing plant molecular composition. Interstellar Lab provides sustainable plant-based ingredient solutions to large health, beauty and F&B companies. Its bio-farming technology has also convinced NASA and ESA, which contracted with the company to adapt the system for space deployment. The company counts 45 engineers, scientists and researchers located between its flagship 65,000SF BioPod Facility and Plant Lab in Ivry-sur-Seine (France), its SpaceLab at NASA KSC Florida (USA) and its Business Hub in San Francisco (USA).
Pierre Krings is the founder of Price Minister.
Show more...Investment focus
- Industry: Construction, Rental, Retail
- Stage:Seed, Series A
- Geography: France
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Jam — Jam uses AI and process optimization to assist students in their daily lives.
- Tracktor — Tracktor is an platform that enables construction companies to rent and purchase construction equipment efficiently.
- Renovation Man — Renovation Man is a provider of services intended to revolutionize the world of renovation work.
Marie is a tech entrepreneur and investor. She co-founded and ran Aiden.ai, a B2B Saas that was acquired by Twitter in 2019. She served as Director of Product at Twitter until November 2022 and left as Twitter was becoming X. She is one of the most active angel investors in Europe with over 25 investments she made in the last three years alone inthe UK, France, the US. 56% of her portfolio has at least one female founder.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: France, United States, The Netherlands
Investor stats
- Total investments: 9
- Round size: Seed $876k–$4.9M; Pre-Seed $1.2M–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- omena — Oména is working on a digital handbook to assist women as they transition through menopause.
- Gigi — Discover withava.ai, the AI launch platform offering cutting-edge AI tools and digital solutions for innovative machine learning applications.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Victor Douce
Show more...Investment focus
- Industry: Health Care, FinTech, Medical
- Stage:Series C, Pre-Seed, Series A
- Geography: United States, France, Germany
Investor stats
- Total investments: 9
- Round size: Series C $175M–$650M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Magnisense — Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de diagnostic propriétaires
- The EVERY Company — The EVERY Company, Formerly Clara Foods making Protein | Vegan Egg Protein Ingredients.
- Terran Biosciences — Terran Biosciences is developing therapeutics and technologies to change the lives of patients with neurological and psychiatric diseases.
Tony Jamous is the CEO and Co-Founder of Oyster. He previously worked at Nexmo as a President.Tony Jamous attended IMD.
Show more...Investment focus
- Industry: Software, SaaS, Developer APIs
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 33
- Round size: Seed $1.3M–$8M; Pre-Seed $125k–$3M; Series A $6.4M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cercli — Cercli is a human resources, modern payroll and employee data platform for the Middle East and North Africa (MENA).
- Jet HR — Jet HR makes managing people incredibly simple: payroll, benefits, devices, compliance and much more. We re-thought the HR function, removing anything that is cumbersome and simplifying any action on employees. We are funded by the best Italian VCs (Exor Ventures, Italian Founders Fund and 6 more) and by the best Italian founders (founders ofCasavo, Satispay, Scalapay, Bending Spoons, Musixmatch, Talent Garden, Oyster HR, etc).
- Kinfolk — Resolve 70% of employee requests, run lifecycle programs on autopilot, gain visibility into service delivery and unlock capacity to scale Workforce Ops.
Philippe Oddo is the CEO and General Manager of ODDO BHF Private Equity. He attended HEC Paris.
Show more...Investment focus
- Industry: Apps, Web3, Banking
- Stage:Seed, Series B, Series C
- Geography: France, United States
Investor stats
- Total investments: 4
- Round size: Seed $1.3M–$2.5M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Jop — A one-stop-shop for urban residents, Jop offers a variety of on-demand services in one convenient, easy-to-use platform. Customers can tap a screen and connect with a professional in their city, whether they are an expert at cleaning apartments, trimming mustaches, walking dogs, doing makeup, DJing, or mixing drinks. Instead of paying a company’soverhead, customers pay a Jopper. Once booked, Joppers arrive right at the customer’s doorstep, ready to work.Founded by Canel Frichet and Sebastian Lombardo, Jop was born as a platform to give people the opportunity to work directly for each other, as opposed to hiring through a company. Joppers set their own pricing and hours. Something else that sets JOP apart from other platforms in the on-demand space is that Joppers earn company equity, which is granted based on level of activity and performance on the platform.
- Theravectys — TheraVectys delivers safe and efficient T-cell vaccines based on its lentiviral vector platform.
- Urgence Docteurs — UrgenceDocteurs is a brand new application. A study shows that 20,000 to 30,000 doctors do not practice in France. Which does not help anyone else Everyone is constantly looking for doctors. Whatever the position of the practitioner: general practitioner, pediatrician, physiotherapist, nurse, osteopath or carer, allows all these professionals todevelop their activity with a minimum of constraints! UrgenceDocteurs has been thought to meet the needs of physicians, who, even with long years of study, do not have the opportunity to leverage their expertise. While medicine studies are very difficult, each year, nearly 25% of thesed doctors do not settle. that 20,000 to 30,000 doctors do not practice in France. Lack of social protection, high installation costs, unsuitable premises or the fear of the administrative are all arguments put forward to explain this observation.
Christophe Cervasel
Show more...Investment focus
- Industry: Wellness, Agriculture, Animal Feed
- Stage:Seed
- Geography: France
Investor stats
- Total investments: 2
- Round size: Seed $1.3M–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- nextProtein — nextProtein is developing a large scale and sustainable insect based source of protein. The bioconversion of fly larvae fed with organic waste generates valuable feed components for fish, livestock and pets.
- Urgence Docteurs — UrgenceDocteurs is a brand new application. A study shows that 20,000 to 30,000 doctors do not practice in France. Which does not help anyone else Everyone is constantly looking for doctors. Whatever the position of the practitioner: general practitioner, pediatrician, physiotherapist, nurse, osteopath or carer, allows all these professionals todevelop their activity with a minimum of constraints! UrgenceDocteurs has been thought to meet the needs of physicians, who, even with long years of study, do not have the opportunity to leverage their expertise. While medicine studies are very difficult, each year, nearly 25% of thesed doctors do not settle. that 20,000 to 30,000 doctors do not practice in France. Lack of social protection, high installation costs, unsuitable premises or the fear of the administrative are all arguments put forward to explain this observation.
Co-Founder @ Alderaan Biotechnology Founder and Scientific Advisor @ Orega Biotech
Show more...Investment focus
- Industry: Medical, Biotechnology, Consumer Research
- Stage:Seed
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ventuno Biotech — Our biotech company is at the forefront of developing innovative cancer therapies. Our approach centers on unlocking the potential of the immune system to
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sebastien Gallice
Show more...Investment focus
- Industry: Medical, 3D Printing, Pharmaceutical
- Stage:Seed
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Gilles Alberici is a pharmacist and doctor of immunology. From 1994 to 1999 he founded and directed Imtix-in Pasteur-Mérieux-then-Imtix SangStat. More recently (1999 to 2007), he developed OPi, Pharmaceuticals for Rare diseases.
Show more...Investment focus
- Industry: Medical, Biotechnology, Consumer Research
- Stage:Seed
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ventuno Biotech — Our biotech company is at the forefront of developing innovative cancer therapies. Our approach centers on unlocking the potential of the immune system to
Philippe du Mesnil, a private investor
Show more...Investment focus
- Industry: Medical, Manufacturing, Medical Device
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ilasis — Discover Rx, the new femtosecond laser for performing a perfect capsulotomy in cataract surgery. Rx is the new innovation of Helix Surgical.
David Amsellem began his career as a founding shareholder of Poweo before continuing his career as an energy trader in Switzerland.In 2007, after this first successful entrepreneurial experience, he identified a market opportunity still in its early stages: private concierge services. David Amsellem created John Paul at age 29, with the goal ofenhancing this new private concierge offer for companies. Some of the major global brands immediately saw the benefit of this groundbreaking concierge business in managing their relationships with their best customers.From the outset David has led the development of John Paul with integrity and innovation and continues to do so today. Under his supervision, John Paul has become the world leader in the concierge market. David Amsellem is now CEO of John Paul Group.
Show more...Investment focus
- Industry: Financial Services, Banking, FinTech
- Stage:Seed, Angel
- Geography: France
Investor stats
- Total investments: 6
- Round size: Seed $1.2M–$3.2M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Joe — Joe is an financial service that reimburses and allows ALL expenses to be paid in several installments.
- uptime.ac — Founded in 2016, uptime's predictive maintenance technology for elevators provides access to data that leads to fewer breakdowns, more uptime and less costs. Elevators with uptime’s artificial intelligence system benefit from real-time data to monitor safety, increase performance and modernise the outdated elevator experience, while theavailability of transparent information strengthens trust between building managers and elevator service providers. uptime’s brand-agnostic offering allows elevator service providers to grow their maintenance portfolios and improve retention rates thanks to fewer failures and more transparency, while residential and commercial buildings rely on uptime technology to enhance the safety and efficiency of their facilities. Today, uptime is used by more than 200 companies in Europe. uptime is headquartered in Paris and London, and plan to expand in multiple countries by 2023. The company is backed by major funds such as Serena Capital, KIMA Ventures and Acequia Capital.
- Urgence Docteurs — UrgenceDocteurs is a brand new application. A study shows that 20,000 to 30,000 doctors do not practice in France. Which does not help anyone else Everyone is constantly looking for doctors. Whatever the position of the practitioner: general practitioner, pediatrician, physiotherapist, nurse, osteopath or carer, allows all these professionals todevelop their activity with a minimum of constraints! UrgenceDocteurs has been thought to meet the needs of physicians, who, even with long years of study, do not have the opportunity to leverage their expertise. While medicine studies are very difficult, each year, nearly 25% of thesed doctors do not settle. that 20,000 to 30,000 doctors do not practice in France. Lack of social protection, high installation costs, unsuitable premises or the fear of the administrative are all arguments put forward to explain this observation.
Laurent SALOMON
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BrightHeart — BrightHeart develops an AI-based platform for fetal ultrasound analysis to improve detection of congenital heart defects.
Dr. Geoffrey Duyk was a member of the Board from May 2006 through May 2011, and re-joined the Board in May 2012. Dr. Duyk is a partner of TPG Growth, LLC, an affiliate of TPG Biotechnology Partners II, L.P.Previously, he served on the board of directors and was President of Research and Development at Exelixis, Inc., a biopharmaceutical companyfocusing on drug discovery, from 1996 to 2003.Prior to Exelixis, Dr. Duyk was Vice President of Genomics and one of the founding scientific staff at Millennium Pharmaceuticals, from 1993 to 1996.Before that, Dr. Duyk was an Assistant Professor at Harvard Medical School in the Department of Genetics and Assistant Investigator of the Howard Hughes Medical Institute.Dr. Duyk currently serves on the boards of directors of several private companies and the non-profit Wesleyan University Board of Trustees. He served on the board of directors of Agria Corporation from August 2007 to May 2009, Cardiovascular Systems, Inc. (formerly Replidyne, Inc.) from 2004 to February 2009, Exelixis, Inc. from 1996 to 2003. Dr. Duyk holds a Bachelor of Arts degree in Biology from Wesleyan University and Doctor of Philosophy and Medicine degrees from Case Western Reserve University.
Show more...Investment focus
- Industry: Biotechnology, Medical, Chemical
- Stage:Series A, Series B, Series C
- Geography: United States, Japan, France
Investor stats
- Total investments: 13
- Round size: Series A $10M–$40M; Series B $15M–$70M; Series C $15M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- DNAnexus — The world's most secure & trusted biomedical cloud platform that accelerates clinical and scientific discovery with the potential to improve patient lives.
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
- Aerie Pharmaceuticals — Aerie Pharmaceuticals, a leading ophthalmic pharmaceuticals company conducting R&D of products for treating patients with glaucoma and other eye diseases.
Giorgio has spent more than 30 years in senior management at high-technology companies, from start-up ventures to international public companies, and has led two successful IPOs. He is chairman of Cube Optics AG and vice president of the executive board at Photonics21.Previously, Giorgio was CEO of Bookham, now Oclaro, which he grew from astart-up into a quarter-billion-dollar NASDAQ-listed public company. He also served as the vice president of sales, finance and business development for Flamel Technologies.Prior to that, he was the founder and general manager of the Miniplex DSL Business Unit at Raychem and strategy consultant at Booz Allen.He has a M.A. degree in physics from Oxford University and a Ph.D. in thermonuclear fusion from Princeton University.
Show more...Investment focus
- Industry: Medical, Biotechnology
- Stage:Seed
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Felix holds a M.S. in Economics from the Ecole polytechnique and Sciences Po. He has worked for Google and McKinsey. He is one of the founders of PriceMatch
Show more...Investment focus
- Industry: SMS, SaaS, FinTech
- Stage:Series A, Seed
- Geography: France, Italy, United States
Investor stats
- Total investments: 5
- Round size: Seed $13M–$33M; Series A $19M–$20M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- RockFi — RockFi is a private management company offering wealth management services.
- Prelude — SMS & OTP verification infrastructure built for developers.
- Parallel 1245 — Parallel builds AI agents that streamline healthcare admin workflows, seamlessly integrated with existing systems to unlock efficiency at scale.
Sacha Loiseau is based out of Paris, Ile-de-France, and is the Founder, CEO, and Chairman of the Board at Mauna Kea Technologies. Sacha previously served as a Board Member at Sonio. Sacha Loiseau attended Université de Paris. Sacha Loiseau has received Marius Lavet Prize "engineer and inventor" award.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Pre-Seed, Series B
- Geography: France
Investor stats
- Total investments: 5
- Round size: Series A $8.2M–$31M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- BrightHeart — BrightHeart develops an AI-based platform for fetal ultrasound analysis to improve detection of congenital heart defects.
Jean-Paul Kress is based out of Paris, Île-de-France and is the Chief Executive Officer and Chairman of the Board of Vor Biopharma and Independent Director of Sanofi. Jean-Paul previously worked at MorphoSys as a CEO. Jean-Paul Kress attended the Université de Paris.
Show more...Investment focus
- Industry: Medical, Biotechnology
- Stage:Seed
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Olivier started his career in 1998 as a Production and Quality Manager for DeliFrance, managing over 50 employees in three shifts, 7 days a week.In 2001, he became Sales Director for IMDS, a leading hosting and IT solutions provider in Western Europe. In 2007, Olivier founded NaturaBuy, a marketplace dedicated to outdoor sports, hunting andfishing, addressing a €2.5 billion market in France. NaturaBuy is now the leading marketplace of its sector, powering tens of thousands of transactions each month and €60 million in annual Transaction Volume.Olivier has backed some the most successful Kerala startups from their creation, such as Doctolib, Malt, admo.tv and Privateaser.Olivier holds a MSc in Engineering.Past and current Boards: Kerala Ventures, NaturaBuy (as CEO)
Show more...Investment focus
- Industry: Medical, Hospital, Health Care
- Stage:Seed
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Doctolib — Doctolib is an online booking platform and management software provider for doctors in Europe working with 65 000 health practitioners, present in 1 300 health facilities. 25 million patients visit Doctolib website and mobile app every month.For doctors, Doctolib is a full-range service to improve bookings management, reduce no-show and bring newpatients to your office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctor or dentist appointments 24/24 and 7/7 within a few clicks.Founded in 2013, Doctolib is based out of Paris, France.
Rémi Gaston- Dreyfus
Show more...Investment focus
- Industry: Medical, Biotechnology
- Stage:Seed
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Jeanne Kehren is the SVP Digital & Commercial Innovation & CIO at Bayer. She attended Alfort National Veterinary School - EnvA.
Show more...Investment focus
- Industry: Medical, Health Care, Neuroscience
- Stage:Seed
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Clarity — Our brain computer interface uses the power of light and sound to treat neurodegenerative diseases, without the need for drugs or implants.
Yann Fleureau is based ourt of France and is the Co-Founder of Project Numina. Yann previously worked at Cardiologs as a Co-founder and General Manager. Yann Fleureau attended Ecole Polytechnique.
Show more...Investment focus
- Industry: Health Care, Medical Device, Gaming
- Stage:Series A, Seed, Pre-Seed
- Geography: France
Investor stats
- Total investments: 7
- Round size: Series A $11M–$31M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
- Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.
- Brink Therapeutics — Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.
Arthur Mensch is the Co-Founder and Chief Executive Officer of Mistral AI. He previously worked at DeepMind as a Staff Research Scientist. Arthur Mensch attended École Polytechnique.
Show more...Investment focus
- Industry: Artificial Intelligence, Medical, Software
- Stage:Series A, Seed, Pre-Seed
- Geography: United States, Spain, France
Investor stats
- Total investments: 6
- Round size: Seed $10M–$41M; Series A $20M–$52M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- Linkup — We're building the next generation web search engine, connecting your applications and AI agents to the internet. https://t.co/a6nJdu6jfZ
- Parallel 1245 — Parallel builds AI agents that streamline healthcare admin workflows, seamlessly integrated with existing systems to unlock efficiency at scale.
Pierre Olivier Goineau - President @ Neuronax
Show more...Investment focus
- Industry: Medical, Biopharma, Health Care
- Geography: France
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ixaltis — Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.The company was born out of the combined expertise of scientists specialized in urology, pharmaceutical experts and experienced managers: Dr. Philippe Lluel, Christian Chavy, Stefano Palea, Dr. Roberto Gradnik andProfessors Pascal Rischmann and Xavier Gamé. The vision of IXALTIS is to develop treatments for genito-urinary tract diseases with still a high unmet medical need, by identifying drugs which had already reached clinical stage and reexplore these for use in genitourinary tract disorders.IXALTIS has established a proprietary position covering Litoxetine for use in urogenital and other disorders based on its specific mechanism of action.
Dominique Vidal is a Venture Partner at Index Ventures.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $1M–$14M; Series A $3.3M–$26M; Series B $10M–$69M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Koyeb — Koyeb is a developer-friendly serverless platform to deploy apps globally. No-ops, servers, and infrastructure management.
- Leavy.co — Leavy.co allows for anyone to live wherever they like, no matter how much they make, even for a day. Covid has turned our idea of work and travel upside down. It’s now all about mobility, for a generation who cannot afford it. The platform pays cash to all members willing to share their homes with the community or care for others.
- Gens de Confiance — It is not enough to offer a wide range of products and services, you have to ensure that everyone is reliable. GensDeConfiance fights against online scams and build trust via a super-secured classifieds ad board. Our classifieds are only accessible to people who are endorsed by at least three other members. And if we have to remove someone, wealso remove all his referrers accounts! Therefore, not only we ensure that just the more reliable people can join, but every member is accountable at any time then.
After launching his first venture in 2000 (exited in 2002), Antoine joined the Travelocity / Lastminute group as Sales Director and then becoming COO. At that time, he directly managed 200 employees, including 50 salespeople.In 2009, he cofounded the “Startup Studio” Otium with Pierre-Edouard Sterin, Smartbox’s founder. Antoine built thefounding team, hiring Stanislas Niox-Château and Philippe de Chanville (5 years later, Stan will found Doctolib and Philippe ManoMano). As Otium CEO, Antoine conducted the acquisition of LaFourchette in 2009, led Lafourchette’s Board for 6 years (the startup grew from 3 to 250 salaries across 4 markets) and conducted the exit process to TripAdvisor in May 2014.Antoine cofounded a total of 6 “Otium” startups, among others Balinea, the leading platform for beauty institute bookings, and Weekendesk, an OTA for weekends generating above €100 million in Transaction Volume in 5 countries.Antoine graduated from HEC Paris.
Show more...Investment focus
- Industry: SaaS, Internet, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: France
Investor stats
- Total investments: 14
- Round size: Seed $329k–$3.2M; Series A $4.4M–$11M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- RockFi — RockFi is a private management company offering wealth management services.
- Doctolib — Doctolib is an online booking platform and management software provider for doctors in Europe working with 65 000 health practitioners, present in 1 300 health facilities. 25 million patients visit Doctolib website and mobile app every month.For doctors, Doctolib is a full-range service to improve bookings management, reduce no-show and bring newpatients to your office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctor or dentist appointments 24/24 and 7/7 within a few clicks.Founded in 2013, Doctolib is based out of Paris, France.
- Delos — The French flair striking hard in AI
Quentin de Metz is the co-founder and CTO of Pennylane.
Show more...Investment focus
- Industry: FinTech, Medical, Hospital
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 4
- Round size: Seed $9M–$33M; Series A $20M–$21M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Spiko — Spiko is a tokenization platform that offers to be the supplier of tokenized Money Market Funds.
- Thunder Code — Transform your QA process with Thunder Code's AI-powered test automation platform. Create, manage, and run automated tests without coding - perfect for QA teams seeking efficiency, reliability, and seamless integration.
- Parallel 1245 — Parallel builds AI agents that streamline healthcare admin workflows, seamlessly integrated with existing systems to unlock efficiency at scale.
Guillaume Amblard
Show more...Investment focus
- Industry: Software, FinTech, Analytics
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, United Kingdom, Tunisia
Investor stats
- Total investments: 11
- Round size: Seed $630k–$9M; Venture - Series Unknown $4.4M–$9.5M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Uptale — Uptale provides an enterprise solution that enhances employee learning through immersive experiences in 360° and virtual reality. The platform allows organizations to create, share, and analyze training modules without requiring technical expertise.
- Wattnow — Wattnow's smart meters and AI show every machine's consumption live and flag waste in time to stop it. Plants cut energy costs by up to 30%.
- Thunder Code — Transform your QA process with Thunder Code's AI-powered test automation platform. Create, manage, and run automated tests without coding - perfect for QA teams seeking efficiency, reliability, and seamless integration.
Medical Angel investor funding in France at a glance
Stats across 38 deals from 50 investors.
Access all 50 angel investors in France Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Angel Investors in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 50 angel investors investing in France Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!